Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.

Irene CacciolaGiuseppina RussoRoberto FilomiaConcetta PitroneGaia CaccamoAnnalisa GiandaliaAngela AlibrandiMaria Stella FranzèSerena PorcariSergio MaimoneCarlo SaittaGiovanni SquadritoGiovanni Raimondo

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

DAA-based HCV cure induces a significant and persistent amelioration of glycaemic control in HCV/diabetic patients with chronic hepatitis, whereas cirrhotic HCV/diabetic subjects have only a transient benefit from the virus elimination.

Keyphrases

hepatitis c virus
type diabetes
human immunodeficiency virus
wound healing
antiretroviral therapy
drug induced